Maldives bans ‘Cofsy’ cough syrup over contamination fears
The Maldives Food and Drug Authority (MFDA) has issued an immediate ban on the import, sale, and use of a particular cough syrup after contaminants were found in the product.
Authorities have discovered that the syrup contains particles, leading to concerns over its safety.
As a precautionary measure, the MFDA has prohibited the import and distribution of this product until further investigations are completed.
The details of the affected syrup are as below:
Generic Name:
Salbutamol Sulphate BP + Ambroxol Hydrochloride BP + Guaiphenesin BP + Menthol BP
Brand/Dosage Form/Strength:
Cofsy Syrup/ 1mg + 15mg + 50mg + 5mg per 5ml (100ml bottle)
Manufacturer/Country of Origin:
Mmc Health Care Ltd. No 34-B, Sidco Industrial Estate, Thirumazhisai, Chennai - 600 124, India
The MFDA is urging the public and businesses to adhere to this directive and refrain from using the product until further notice.
For additional information or inquiries, individuals can reach out to the MFDA hotline at 7200321.
Advertisement
